Retro Biosciences
Drug Discovery

Retro Biosciences news and milestones

Retro Biosciences: 7 headlines on record, 0 headlines in the last 90 days. Its story counts 1 milestone.

Data updated Nov 16, 2026 · Back to the company report
7Headlines
0In 90 days
1Milestones

Headlines

Sep 14, 20252025
News · Business Insider
Retro Biosciences is set to run a clinical trial for an aging drug designed to reverse Alzheimer's, its CEO Joe Betts-LaCroix, told Business Insider.
Aug 23, 20252025
May 21, 20252025
News · Observer
Retro Biosciences, a longevity startup funded by OpenAI's Sam Altman, hopes that blood stem cell research will aid in anti-aging efforts.
Jan 28, 20252025
News · YahooFinance
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human…
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Retro Biosciences, News. Alion, Nov 16, 2026. https://alion.io/company/retro/news

.json · .md · CC BY-SA 4.0